(603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Repurchasing Shares
Filed with SSE · Stock code 603079 · · 2 pages · Chinese
Summary by 6ix AI
Zhejiang Shengda Bio-Pharm Co., Ltd. has announced progress on its share repurchase plan.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix
Story so far
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
- Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management
Earlier from Zhejiang Shengda Bio-Pharm
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management
- (603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Redemption upon Maturity of Cash Management Products Purchased with Idle Raised Funds
- Announcement on Progress in Opening Dedicated Settlement Account for Cash Management Products Purchased with Raised Funds and Using Idle Raised Funds for Cash Management
- Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
- Announcement on Progress in Repurchasing Shares
Follow Zhejiang Shengda Bio-Pharm into a list and get an email when it puts out news.
Follow Zhejiang Shengda Bio-Pharm